Literature DB >> 8160725

Recent advances in the management of gallstones.

C F Gholson1, K Sittig, J C McDonald.   

Abstract

Demands for less invasive, more cost-effective therapy have revolutionized the management of gallstones over the past 10 years. There are no reliable methods of permanently reversing the pathophysiologic defects that cause gallstones. Open cholecystectomy (OC), the gold standard for managing symptomatic cholelithiasis, has been largely replaced by laparoscopic cholecystectomy (LC), which has the advantages of a minimal hospital stay and quicker return to work. Other adjunctive therapies, limited in applicability to selected patients, include oral bile acid therapy (BAT), dissolutional agents, and extracorporeal shock wave lithotripsy. Choledocholithiasis (CDL), formerly managed exclusively with surgical common duct exploration, is increasingly treated with therapeutic biliary endoscopy. Methods of laparoscopic common bile duct exploration are being developed. Optimal algorithms for applying these techniques to patients undergoing LC are evolving. In a sense, the solution to all, or certainly most, gallstones now can be seen through a scope.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160725     DOI: 10.1097/00000441-199404000-00010

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Suspected biliary complications after laparoscopic and open cholecystectomy leading to endoscopic cholangiography: a retrospective comparison.

Authors:  C F Gholson; C Dungan; G Neff; R Ferguson; D Favrot; I Nandy; P Banish; K Sittig
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

2.  Role of ERCP in the era of laparoscopic cholecystectomy for the evaluation of choledocholithiasis in sickle cell anemia.

Authors:  Hussain Issa; Ahmed H Al-Salem
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

3.  Sickle cell cholangiopathy: an endoscopic retrograde cholangiopancreatography evaluation.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed Al-Salem
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

4.  Choledocholithiasis in patients with normal serum liver enzymes.

Authors:  D E Goldman; C F Gholson
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

5.  ERCP in Patients With Sickle Cell Disease: Diagnostic and Therapeutic Dilemmas.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-03-20

Review 6.  Hepatobiliary Manifestations of Sickle Cell Anemia.

Authors:  Hussain Issa; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.